Anesthetic Success Rate of Inferior Alveolar Nerve Block for Mandibular Molars with Symptomatic Irreversible Pulpitis in Women Taking Antidepressants
Iranian Endodontic Journal,
Vol. 17 No. 2 (2022),
5 April 2022
,
Page 52-56
https://doi.org/10.22037/iej.v17i2.34921
Abstract
Introduction: This randomized controlled clinical study sought to evaluate the success rate of inferior alveolar nerve block (IANB) during the endodontic management of mandibular molars with symptomatic irreversible pulpitis in women taking selective serotonin reuptake inhibitor (SSRI) antidepressants. Materials and Methods: Ninety adult female patients over 18 years of age who were diagnosed with symptomatic irreversible pulpitis of a mandibular molar were recruited in this study. The patients were equally assigned to SSRI user group (including citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline), who had taken an SSRI, and non-SSRI user group, who had not taken any SSRIs at all. All patients in both groups received 3.6 mL of 2% lidocaine with 1:80,000 epinephrine using conventional IANB injection. Access cavity was prepared 15 min after the injection. Lip numbness was necessary for all patients. Success was determined as no or mild pain upon access cavity preparation and/or instrumentation based on the Heft-Parker visual analog scale recordings. Data were analyzed using the chi-square test Mann-Whitney U test, and t-test. Results: The success rate was 55.6% for SSRI users and 44.4% for non-SSRI users, and no statistically significant difference was observed between the two groups (x2=1.1, P=0.292). Conclusions: Based on the results of this study, taking SSRI antidepressants could not affect the anesthetic success rate of IANB for mandibular molars with symptomatic irreversible pulpitis in women.
- Anesthesia; Antidepressants; Inferior Alveolar Nerve Block; Pulpitis; Selective Serotonin Reuptake Inhibitors
How to Cite
References
1. Gao X, Meng K. Comparison of articaine, lidocaine and mepivacaine for buccal infiltration after inferior alveolar nerve block in mandibular posterior teeth with irreversible pulpitis. Br Dent J. 2020;228(8):605-8.
2. Mousavi SA, Sadaghiani L, Shahnaseri S, Zandian A, Farnell DJJ, Vianna ME. Effect of magnesium sulphate added to lidocaine on inferior alveolar nerve block success in patients with symptoms of irreversible pulpitis: a prospective, randomized clinical trial. Int Endod J. 2020;53(2):145-53.
3. Ghoddusi J, Zarrabi MH, Daneshvar F, Naghavi N. Efficacy of IANB and Gow-Gates techniques in mandibular molars with symptomatic irreversible pulpitis: a prospective randomized double blind clinical study. Iran Endod J. 2018;13(2):143-8.
4. Hargreaves KM, Keiser K. Local Anesthetic Failure in Endodontics. Endodontic Topics. 2002;1(1):26-39.
5. Esmaeili A, Akhavan A, Bouzari M, Mousavi S, Torabinia N, Adibi S. Temporal expression pattern of sodium channel Nav 1.8 messenger RNA in pulpitis. Int Endod J. 2011;44:499-504.
6. Amiri S, Haj-Mirzaian A, Rahimi-Balaei M, Razmi A, Kordjazy N, Shirzadian A, et al. Co-occurrence of Anxiety and Depressive-like Behaviors Following Adolescent Social Isolation in Male Mice; Possible Role of Nitrergic System. Physiol Behav. 2015;145:38-44.
7. Van de Velde S, Bracke P, Levecque K. Gender differences in depression in 23 European countries. Cross-national variation in the gender gap in depression. Soc Sci Med. 2010;71(2):305-13.
8. Couzin J. Psychopharmacology. Volatile Chemistry: Children and Antidepressants. Science. 2004;305(5683):468-70.
9. Dale E, Bang-Andersen B, Sanchez C. Emerging Mechanisms and Treatments for Depression Beyond SSRIs and SNRIs. Biochem pharmacol. 2015;95(2):81-97.
10. Kesic M, Tvrdeic A, Kolaric D, Stojkovic R, Cicin-Sain L. Serotonergic modulation of pain and analgesic responses: a study in rats with constitutionally altered serotonin transporters. Eur J Pain. 2015;19:508-515.
11. Viguier F, Michot B, Hamon M, Bourgoin S. Multiple roles of serotonin in pain control mechanisms--implications of 5-HT(7) and other 5-HT receptor types. Eur J Pharmacol. 2013;716:8-16.
12. Nielsen M, Gotzsche P. An analysis of psychotropic drug sales. Increasing sales of selective serotonin reuptake inhibitors are closely related to number of products. Int J Risk Saf Med. 2011;23:125-132.
13. Katzung BG. Basic and Clinical Pharmacology, 14th ed. New York: Mc Graw-Hill Companies; 2018;30:546.
14. Becker DE. Psychotropic Drugs: Implications for Dental Practice. Anesth Prog. 2008;55:89-99.
15. Lindemann M, Reader A, Nusstein J, Drum M, Beck M. Effect of sublingual triazolam on the success of inferior alveolar nerve block in patients with irreversible pulpitis. J Endod. 2008;34:1167-1170.
16. Shetkar P, Jadhav GR, Mittal P, Surapaneni S, Kalra D, Sakri M, et al. Comparative evaluation of effect of preoperative alprazolam and diclofenac potassium on the success of inferior alveolar, Vazirani-Akinosi, and Gow-Gates techniques for teeth with irreversible pulpitis: Randomized controlled trial. J Conserv Dent. 2016;19:390-395.
17. MacDonald E, Drum M, Nusstein J, Fowler S, Beck M, Reader A. Anesthetic success using nitrous oxide and a combination of lidocaine/clonidine for the inferior alveolar nerve block and the effects on blood pressure and pulse in patients with symptomatic irreversible pulpitis: a prospective, randomized, double-blind study. Journal of Endodontics 2021;47(4):558-565.
18. Corah NL, Gale EN, Illig SJ. Assessment of a dental anxiety scale. J Am Dent Assoc. 1978;97:816-819.
19. Heft MW, Parker SR. An experimental basis for revising the graphic rating scale for pain. Pain. 1984;19:153-161.
20. Frackiewicz EJ, Sramek JJ, Cutler NR. Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother. 2000;34:80-88.
21. Berkley KJ. Sex differences in pain. Behavioral and Brain Sciences. 1997;20:371-380.
22. Boucher Y, Matossian L, Rilliard F, Machtou P. Radiographic evaluation of the prevalence and technical quality of root canal treatment in a French subpopulation. Int Endod J. 2002;35:229-238.
23. Dankoski EC, Carroll S, Wightman RM. Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin release. J Neurochem. 2016;136:1131-1141.
24. Nusstein J, Reader A, Nist R, Beck M, Meyers WJ. Anesthetic efficacy of the supplemental intraosseous injection of 2% lidocaine with 1:100,000 epinephrine in irreversible pulpitis. J Endod. 1998;24:487-491.
25. Kreimer T, Kiser R, Reader A, Nusstein J, Drum M, Beck M. Anesthetic efficacy of combinations of 0.5 mol/L mannitol and lidocaine with epinephrine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis. J Endod. 2012;38:598-603.
26. Fullmer S, Drum M, Reader A, Nusstein J, Beck M. Effect of preoperative acetaminophen/hydrocodone on the efficacy of the inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: a prospective, randomized, double-blind, placebo-controlled study. J Endod. 2014;40:1-5.
27. Oleson M, Drum M, Reader A, Nusstein J. Effect of preoperative ibuprofen on the success of the inferior alveolar nerve block in patients with irreversible pulpitis. J Endod. 2010;36:379-782.
28. Albert PR, Benkelfat C, Descarries L. The neurobiology of depression-revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. The Royal Society. 2012;367:2378-2381.
29. Finocchi C, Villani V, Casucci G. Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurol Sci. 2010;31:95-98.
30. Tynan RJ, Weidenhofer J, Hinwood M, Cairns M, Day T, Walker F. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun. 2012;26:469-479.
31. Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012;52
- Abstract Viewed: 285 times
- PDF Downloaded: 204 times